GLENMEDE TRUST CO NA - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 121 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.69 and the average weighting 0.0%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$11,000
+22.2%
2,824
+5.2%
0.00%
Q2 2020$9,000
+80.0%
2,684
+66.1%
0.00%
Q1 2020$5,0000.0%1,6160.0%0.00%
Q4 2019$5,000
+25.0%
1,616
+202.1%
0.00%
Q3 2019$4,000
+33.3%
535
+51.6%
0.00%
Q2 2019$3,0000.0%3530.0%0.00%
Q1 2019$3,000
-70.0%
353
-71.1%
0.00%
Q4 2018$10,000
-86.8%
1,223
-73.6%
0.00%
Q3 2018$76,000
+20.6%
4,624
+53.2%
0.00%
Q2 2018$63,000
-79.5%
3,019
-92.7%
0.00%
-100.0%
Q2 2013$308,000
+63.0%
41,462
+63.2%
0.00%
-76.5%
Q1 2013$189,000
-92.0%
25,404
-88.0%
0.02%
-93.0%
Q4 2012$2,377,000
+6.0%
212,568
+10.9%
0.24%
-0.4%
Q3 2012$2,243,000
+416.8%
191,753
+547.8%
0.24%
+920.8%
Q1 2012$434,00029,6000.02%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q2 2013
NameSharesValueWeighting ↓
Piermont Capital Management Inc. 312,842$2,033,0000.48%
BARD ASSOCIATES INC 648,525$4,215,0000.39%
Sonora Investment Management, LLC 233,295$1,516,418,0000.30%
Nine Chapters Capital Management LLC 32,400$211,0000.28%
Alambic Investment Management, L.P. 287,601$1,869,0000.23%
Granite Investment Partners, LLC 201,221$1,308,0000.09%
Renaissance Technologies 5,679,800$36,919,0000.05%
PDT Partners, LLC 123,200$801,0000.04%
ClariVest Asset Management LLC 242,050$1,573,0000.04%
KENNEDY CAPITAL MANAGEMENT LLC 315,934$2,054,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders